Use of a novel herbal medicine in a 75-year-old woman with multi-metastatic pancreatic cancer: A case report and review of the literature.

摘要: Pancreatic cancer is one of the most aggressive types malignant tumors and associated with an extremely poor prognosis. Despite numerous research efforts over last few years, little progress has been made in understanding treatment disease. Gemcitabine-based regimens are considered as first-line for pancreatic cancer, but effects chemotherapy on disease limited. Natural products extracted from herbs represent a valuable resource novel bioactive anticancer agents could benefit multi-metastasis adenocarcinoma patients Eastern Cooperative Oncology Group status 3. Biological intra-control (BICT) systemic therapy involving palliative care herbal extract combinations [including ginseng (Panax C.A. Mey.), Herba Agrimonia (Agrimonia pilosa Ledeb.), White Flower Patrinia Herb (Thlaspi arvense Linn.) arginine], which approved by State Food Drug Association. The intended to regulate inhibit blood vessel generation tumor growth inhibiting epidermal factor receptor vascular endothelial expression, manage symptoms improve quality treatment. present study discusses case 75-year-old female diagnosed multiple metastases liver lymph nodes. patient was administered BICT achieved survival 11 months without side-effects severity greater than grade 1 according Common Terminology Criteria Adverse Events. also describes possible approach providing treating late-stage, metastatic adenocarcinomas elderly patients.